1.1.1.10	2-mercaptoethanol	92% inhibition at 5 mM	63	
1.1.1.10	3-hydroxybutyric acid	50% inhibition at 1.1 mM	19980	
1.1.1.10	3-hydroxybutyric acid	50% inhibition at 1.0 mM	19980	
1.1.1.10	3-hydroxybutyric acid	50% inhibition at 2.0 mM	19980	
1.1.1.10	4-methyl-[1,2,3]-thiadiazole-5-carboxylic acid benzyloxyamide	-	17975	
1.1.1.10	4-methyl-[1,2,3]-thiadiazole-5-carboxylic acid benzyloxyamide	IC50: 0.00023 mM for wild-type enzyme, 0.0019 mM for mutant enzyme L143F, 0.0018 mM for mutant enzyme H146L, 0.0029 mM for mutant enzyme W191S, 0.00079 mM for mutant enzyme W191F	17975	
1.1.1.10	4-methylthiophene-2-carboxylic acid N'-(2,3,3-trichloroacryloyl)-hydrazide	IC50: 0.0003 mM for wild-type enzyme, 0.00056 mM for mutant enzyme L143F, 0.002 mM for mutant enzyme H146L, 0.0002 mM for mutant enzyme W191S, 0.0022 mM for mutant enzyme W191F	60352	
1.1.1.10	acetoacetic acid	50% inhibition at 0.63 mM	10562	
1.1.1.10	acetoacetic acid	50% inhibition at 1.8 mM	10562	
1.1.1.10	acetoacetic acid	50% inhibition at 2.5 mM	10562	
1.1.1.10	aminopyrine	70 mM	32147	
1.1.1.10	cysteine	the addition of cysteine (more than 2 mM) inactivates human L-xylulose reductase and is accompanied by a 10fold decrease in catalytic efficiency, the activity of the cysteine-inactivated enzyme is not recovered by the addition of 10 mM dithiothreitol and 2-mercaptoethanol	153	
1.1.1.10	fluoride	50 mM	407	
1.1.1.10	heptanoic acid	50% inhibition at 0.38 mM	4648	
1.1.1.10	heptanoic acid	50% inhibition at 1.4 mM	4648	
1.1.1.10	heptanoic acid	50% inhibition at 2.0 mM	4648	
1.1.1.10	heptanoic acid	50% inhibition at 2.5 mM	4648	
1.1.1.10	hexanoic acid	50% inhibition at 0.10 mM	2964	
1.1.1.10	hexanoic acid	50% inhibition at 0.40 mM	2964	
1.1.1.10	hexanoic acid	50% inhibition at 1.1 mM	2964	
1.1.1.10	hexanoic acid	50% inhibition at 0.42 mM	2964	
1.1.1.10	iodoacetate	not inhibitory	93	
1.1.1.10	iodoacetate	complete inhibition of L-xylulose reductive activity at 5 mM	93	
1.1.1.10	additional information	not: EDTA	2	
1.1.1.10	additional information	modelling of structure-based inhibitor binding into the active site	2	
1.1.1.10	additional information	acetic acid, threonic acid, and octanoic acid are poor inhibitors	2	
1.1.1.10	additional information	acetic acid is a poor inhibitor	2	
1.1.1.10	additional information	acetic acid, acetoacetic acid, 3-OH-butyric acid, and octanoic acid are poor inhibitors	2	
1.1.1.10	additional information	acetic acid, oxaloacetic acid, and octanoic acid are poor inhibitors	2	
1.1.1.10	additional information	the level of xylose reductase decreases when the initial xylose concentration is increased from 30 to 70 g/l	2	
1.1.1.10	n-butyric acid	binds to the active site of the enzyme, complex structure determination and analysis	3528	
1.1.1.10	n-butyric acid	specific, binds to the enzyme-NADP+ complex, the mutant enzymes show altered sensitivity to inhibition, overview	3528	
1.1.1.10	n-butyric acid	50% inhibition at 0.064 mM	3528	
1.1.1.10	n-butyric acid	50% inhibition at 0.026 mM	3528	
1.1.1.10	n-butyric acid	50% inhibition at 0.05 mM	3528	
1.1.1.10	n-butyric acid	50% inhibition at 0.052 mM	3528	
1.1.1.10	octanoic acid	50% inhibition at 2.5 mM	1649	
1.1.1.10	oxaloacetic acid	50% inhibition at 0.91 mM	2862	
1.1.1.10	oxaloacetic acid	50% inhibition at 2.5 mM	2862	
1.1.1.10	p-chloromercuribenzoate	-	43	
1.1.1.10	pentanoic acid	50% inhibition at 0.15 mM	12653	
1.1.1.10	pentanoic acid	50% inhibition at 0.20 mM	12653	
1.1.1.10	pentanoic acid	50% inhibition at 0.38 mM	12653	
1.1.1.10	pentanoic acid	50% inhibition at 0.5 mM	12653	
1.1.1.10	phosphate buffer	-	5262	
1.1.1.10	potassium phosphate	when the purified enzyme containing 2 mM 2-mercaptoethanol is diluted with 10 mM potassium phosphate pH 7.0, its diacetyl reductase activity is gradually decreased	1510	
1.1.1.10	propionic acid	50% inhibition at 0.38 mM	1724	
1.1.1.10	propionic acid	50% inhibition at 0.096 mM	1724	
1.1.1.10	propionic acid	50% inhibition at 0.17 mM	1724	
1.1.1.10	propionic acid	50% inhibition at 0.13 mM	1724	
1.1.1.10	Pyruvic acid	50% inhibition at 0.50 mM	1725	
1.1.1.10	Pyruvic acid	50% inhibition at 0.88 mM	1725	
1.1.1.10	Pyruvic acid	50% inhibition at 1.5 mM	1725	
1.1.1.10	Pyruvic acid	50% inhibition at 1.0 mM	1725	
1.1.1.10	threonic acid	50% inhibition at 0.75 mM	34555	
1.1.1.10	threonic acid	50% inhibition at 1.5 mM	34555	
1.1.1.10	threonic acid	50% inhibition at 1.9 mM	34555